R. Menzies

发表

MODERN TRENDS IN MORTALITY FROM MENINGOCOCCAL DISEASE IN AUSTRALIA

N. Wood, R. Booy, P. McIntyre, 2009, The Pediatric infectious disease journal.

Severity of the 2019 influenza season in Australia- a comparison between 2017 and 2019 H3N2 influenza seasons

M. Trent, R. Menzies, A. Moa, 2019 .

Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2009.

R. Menzies, G. Lawrence, D. Mahajan, 2011, Communicable diseases intelligence quarterly report.

Surveillance of adverse events following immunisation: Australia, 2000-2002.

D. Isaacs, N. Wood, P. Purcell, 2003, Communicable diseases intelligence quarterly report.

Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.

P. Beutels, J. Wood, A. Newall, 2017, Vaccine.

Australia's notifiable diseases status, 2006: annual report of the National Notifiable Diseases Surveillance System.

R. Owen, P. McIntyre, D. Coleman, 2008, Communicable diseases intelligence quarterly report.

Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical.

P. Beutels, P. Beutels, J. Wood, 2016, Vaccine.

A randomised controlled trial of SMS messaging and calendar reminders to improve vaccination timeliness in infants.

H. Marshall, M. McMillan, R. Menzies, 2020, Vaccine.

The epidemiology of respiratory syncytial virus infections in NSW children, 1992–1997

R. Menzies, S. Lister, P. Mcintyre, 2000 .

Vaccine preventable diseases and vaccination policy for indigenous populations.

R. Singleton, R. Menzies, 2009, Pediatric clinics of North America.

An evaluation of the Australian National Serosurveillance Program.

S. Deeks, P. McIntyre, R. Menzies, 2010, Communicable diseases intelligence quarterly report.

Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program

A. Dey, K. Macartney, R. Menzies, 2012, The Medical journal of Australia.

Reduction in Hospitalizations for Pneumonia Associated With the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia

P. McIntyre, R. Menzies, A. Jardine, 2010, The Pediatric infectious disease journal.

Predictors of In-Hospital Mortality in Aboriginal Children Admitted to a Tertiary Paediatric Hospital

R. Menzies, K. Zwi, Rebecca Singer, 2019, International journal of environmental research and public health.

Vaccine myopia: adult vaccination also needs attention

C. Macintyre, J. Leask, R. Menzies, 2017, The Medical journal of Australia.

Barriers and facilitators of immunisation in refugees and migrants in Australia: an east-African case study.

H. Seale, Ikram Abdi, R. Menzies, 2019, Vaccine.

Immunisation issues for Indigenous Australian children

R. Andrews, R. Menzies, 2014, Journal of paediatrics and child health.

Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002.

P. McIntyre, R. Menzies, F. Beard, 2004, Communicable diseases intelligence quarterly report.

Vaccine preventable diseases and vaccination coverage of Indigenous people Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islanders people , Australia , 1999 to 2002

P. McIntyre, R. Menzies, F. Beard, 2004 .

Estimating pertussis incidence in general practice using a large Australian primary care database.

Bette C Liu, J. Wood, A. Newall, 2021, Vaccine.

Has pertussis increased in NSW over the past decade? An evaluation using hospitalisation and mortality data versus notifications 1988-2002.

P. McIntyre, R. Menzies, Han Wang, 2003, New South Wales public health bulletin.

Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience.

B. Hull, K. Macartney, P. McIntyre, 2013, Vaccine.

Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, Australia.

Leo F. Nolan, K. O'Brien, A. Leach, 2007, Vaccine.

Update on childhood pneumococcal vaccination

P. McIntyre, G. Ridley, R. Menzies, 2008 .

The impact of the changing pneumococcal national immunisation program among older Australians.

A. Cripps, R. Booy, J. Litt, 2020, Vaccine.

The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia.

P. Beutels, C. Macintyre, J. Wood, 2018, Vaccine.

Determining the contribution of Streptococcus pneumoniae to community‐acquired pneumonia in Australia

P. McIntyre, R. Menzies, J. Yin, 2017, The Medical journal of Australia.

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians.

P. Beutels, C. Macintyre, J. Wood, 2017, Vaccine.

Long-term Impact of a “3 + 0” Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002–2014

C. Blyth, P. McIntyre, V. Krause, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake

Bette C Liu, J. Kaldor, C. Macintyre, 2016, BMC Infectious Diseases.

Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System.

R. Owen, F. Kong, K. Hope, 2007, Communicable diseases intelligence quarterly report.

Australia's notifiable diseases status, 2004, annual report of the National Notifiable Diseases Surveillance System.

M. Kirk, S. Firestone, B. Hull, 2006, Communicable diseases intelligence quarterly report.

Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older

P. McIntyre, V. Krause, R. Menzies, 2014, The Medical journal of Australia.

General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events.

A. Dey, P. McIntyre, R. Menzies, 2014, Vaccine.

Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines in a Schedule Without a Booster Dose: A 10-Year Observational Study

H. Quinn, P. McIntyre, R. Menzies, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Supplementary report: Surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011.

P. McIntyre, R. Menzies, K. Macartney, 2012, Communicable diseases intelligence quarterly report.

Immunisation coverage annual report, 2013.

A. Dey, B. Hull, J. Brotherton, 2016, Communicable diseases intelligence quarterly report.

Immunisation coverage, 2012.

A. Dey, B. Hull, J. Brotherton, 2014, Communicable diseases intelligence quarterly report.

Immunisation coverage annual report, 2011.

A. Dey, B. Hull, J. Brotherton, 2013, Communicable diseases intelligence quarterly report.

Annual immunisation coverage report, 2010.

A. Dey, B. Hull, P. McIntyre, 2013, Communicable diseases intelligence quarterly report.

Immunisation Coverage Annual Report 2019.

A. Dey, B. Hull, P. McIntyre, 2021, Communicable diseases intelligence.

The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules.

H. Quinn, P. McIntyre, R. Menzies, 2011, New South Wales public health bulletin.

The role of chronic disease in the disparity of influenza incidence and severity between indigenous and non-indigenous Australian peoples during the 2009 influenza pandemic

R. Booy, R. Menzies, R. Dixit, 2022, BMC Public Health.

What isn't measured isn't done – eight years with no progress in Aboriginal and Torres Strait Islander adult influenza and pneumococcal vaccination

Richard J. K. Taylor, R. Menzies, V. Matthews, 2019, Australian and New Zealand journal of public health.

Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.

D. Lehmann, P. McIntyre, V. Krause, 2015, Vaccine.

The Impact of Pneumococcal Conjugate Vaccine on Rates of Myringotomy With Ventilation Tube Insertion in Australia

S. Deeks, P. McIntyre, R. Menzies, 2009, The Pediatric infectious disease journal.

School-based vaccination in NSW.

H. Quinn, R. Menzies, S. Campbell-Lloyd, 2010, New South Wales public health bulletin.

Intussusception After Monovalent Human Rotavirus Vaccine in Australia: Severity and Comparison of Using Healthcare Database Records Versus Case Confirmation to Assess Risk

A. Dey, H. Quinn, N. Wood, 2014, The Pediatric infectious disease journal.

Immunisation coverage of Queensland Indigenous two‐year‐old children by cluster sampling and by register

Gail M. Williams, C. Shannon, R. Menzies, 2007, Australian and New Zealand journal of public health.

Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older

P. McIntyre, V. Krause, R. Menzies, 2014, The Medical journal of Australia.

Vaccine preventable diseases and vaccination policy for indigenous populations.

Peter McIntyre, P. McIntyre, R. Menzies, 2006, Epidemiologic reviews.

Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005.

B. Hull, R. MacIntyre, H. Quinn, 2007, Communicable diseases intelligence quarterly report.

Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease

N. Wood, P. McIntyre, R. Menzies, 2005, Internal medicine journal.

Annual report: surveillance of adverse events following immunisation in Australia, 2008.

M. Gold, P. McIntyre, R. Menzies, 2009, Communicable diseases intelligence quarterly report.

Vaccine preventable diseases in Australia, 2005 to 2007.

Andrew Jardine, Robert Booy, Kristine Macartney, 2010, Communicable diseases intelligence quarterly report.

Improving immunisation timeliness in Aboriginal children through personalised calendars

Penelope A Abbott, J. Davison, R. Menzies, 2013, BMC Public Health.

Immunisation coverage annual report, 2008.

A. Dey, B. Hull, P. McIntyre, 2010, Communicable diseases intelligence quarterly report.

Immunisation coverage annual report, 2007.

S. Deeks, B. Hull, P. McIntyre, 2009, Communicable diseases intelligence quarterly report.

Annual report: Surveillance of adverse events following immunisation in Australia, 2011.

A. Dey, K. Macartney, R. Menzies, 2012, Communicable diseases intelligence quarterly report.

Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia.

C. Macintyre, J. Wood, P. McIntyre, 2013, Vaccine.

Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination.

C. Macintyre, G. Gilbert, H. Quinn, 2012, Vaccine.

A history of adolescent school based vaccination in Australia.

H. Quinn, P. McIntyre, R. Menzies, 2013, Communicable diseases intelligence quarterly report.

Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future

C. Macintyre, J. Wood, A. Newall, 2014, Epidemiology and Infection.

How reliable are Australian Childhood Immunisation Register coverage estimates for indigenous children? An assessment of data quality and coverage.

R. Menzies, C. Rank, 2007, Communicable diseases intelligence quarterly report.

Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses.

P. Beutels, J. Wood, A. Newall, 2014, Vaccine.

Annual report: surveillance of adverse events following immunisation in Australia, 2010.

P. McIntyre, R. Menzies, K. Macartney, 2011, Communicable diseases intelligence quarterly report.

Surveillance of adverse events following immunisation in Australia annual report, 2013.

A. Dey, R. Menzies, K. Macartney, 2015, Communicable diseases intelligence quarterly report.

Surveillance of adverse events following immunisation in Australia, 2012.

A. Dey, R. Menzies, K. Macartney, 2014, Communicable diseases intelligence quarterly report.

Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012.

A. Dey, K. Macartney, R. Menzies, 2013, Communicable diseases intelligence quarterly report.

Controlling measles in NSW: how are we doing in the context of other countries in the Western Pacific?

D. Durrheim, M. Burgess, R. Menzies, 2012, New South Wales public health bulletin.

NSW annual report describing adverse events following immunisation, 2011.

K. Macartney, R. Menzies, D. Mahajan, 2012, New South Wales public health bulletin.

NSW annual report describing adverse events following immunisation, 2010.

R. Menzies, D. Mahajan, S. Campbell-Lloyd, 2011, New South Wales public health bulletin.

Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010.

R. Menzies, K. Macartney, D. Mahajan, 2011, Communicable diseases intelligence quarterly report.

Evaluation of Australia's varicella vaccination program for children and adolescents.

A. Dey, B. Hull, H. Quinn, 2013, Vaccine.

The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia Pacific region

C. Chiu, P. Buchy, K. Jung, 2021, Expert review of vaccines.

Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data.

Bette C Liu, A. Dey, K. Canfell, 2015, The Journal of infectious diseases.

Pneumonia in Elderly Australians: Reduction in Presumptive Pneumococcal Hospitalizations but No Change in All-Cause Pneumonia Hospitalizations Following 7-Valent Pneumococcal Conjugate Vaccination.

P. McIntyre, R. Menzies, A. Jardine, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diagnostic testing and discharge coding for whooping cough in a children's hospital

P. McIntyre, R. Menzies, G. Bonacruz-Kazzi, 2003, Journal of paediatrics and child health.

Immunisation: reducing health inequality for Indigenous Australians

P. McIntyre, R. Menzies, 2005, The Medical journal of Australia.

Informing the design of a whole of life immunisation register for Australia.

H. Seale, A. Heywood, J. Brotherton, 2023, Vaccine.

Equity in disease prevention: Vaccines for the older adults - a national workshop, Australia 2014.

T. Adair, J. Travaglia, M. Woodward, 2016, Vaccine.

Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.

P. McIntyre, R. Menzies, C. Lowbridge, 2013, Communicable diseases intelligence quarterly report.

Annual report: surveillance of adverse events following immunisation in Australia, 2009.

M. Gold, P. McIntyre, R. Menzies, 2010, Communicable diseases intelligence quarterly report.

Modelling the influenza disease burden in people aged 50–64 and ≥65 years in Australia

C. Macintyre, R. Menzies, J. K. Yin, 2021, Influenza and other respiratory viruses.

VALIDATION OF REPORTED RISK EXPOSURE IN PERSONS WITH NEWLY DIAGNOSED HIV INFECTION

R. Menzies, M. Levy, S. Raman, 1996 .

No evidence of increasing Haemophilus influenzae non-b infection in Australian Aboriginal children

P. McIntyre, R. Menzies, P. Markey, 2013, International journal of circumpolar health.

Epidemiology of severe hepatitis A in Indigenous Australian children

D. Isaacs, B. Hull, P. McIntyre, 2007, Journal of paediatrics and child health.

The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia.

P. McIntyre, M. Ferson, R. Menzies, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Communicable disease surveillance during the Sydney 2000 Olympic and Paralympic Games.

R. Menzies, 2000, New South Wales public health bulletin.

Cytomegalovirus‐related childhood mortality in Australia 1999–2011

N. Badawi, H. Smithers-Sheedy, C. Raynes-Greenow, 2015, Journal of paediatrics and child health.

Predicting localised measles outbreak potential in Australia.

C. Macintyre, A. Heywood, J. Wood, 2015, Vaccine.

Vaccine coverage in children born to migrant mothers in Australia: A population-based cohort study.

H. Seale, R. Leong, Ikram Abdi, 2021, Vaccine.

Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.

P. McIntyre, R. Menzies, C. Chiu, 2008, Communicable diseases intelligence quarterly report.

Diphtheria immunity in Australia: should we be concerned?

H. Quinn, P. McIntyre, R. Menzies, 2018, Infectious disorders drug targets.

Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination.

P. McIntyre, R. Menzies, Veronica Kolos, 2007, Vaccine.

Estimating Vaccine Coverage from Serial Trivariate Serologic Data in the Presence of Waning Immunity

N. Hens, N. Goeyvaerts, C. Macintyre, 2015, Epidemiology.

Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data

Bette C Liu, A. Dey, K. Canfell, 2015, BMC Infectious Diseases.

Tetanus immunity and epidemiology in Australia, 1993-2010.

H. Quinn, P. McIntyre, R. Menzies, 2018, Infectious disorders drug targets.

Vaccine myopia: adult vaccination also needs attention

C. Macintyre, R. Menzies, J. Royle, 2017, The Medical journal of Australia.

NSW Annual Adverse Events Following Immunisation Report, 2009.

R. Menzies, D. Mahajan, Ilnaz Roomiani, 2010, New South Wales public health bulletin.

Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.

P. Beutels, C. Macintyre, J. Wood, 2018, Vaccine.

Immunisation against Haemophilus influenzae type b.

R. Menzies, M. Levy, 1995, Australian journal of public health.

Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice

N. Stocks, K. Macartney, D. González-Chica, 2020, Human vaccines & immunotherapeutics.

Invasive pneumococcal disease in Australia 2007 and 2008.

V. Krause, R. Menzies, H. Cook, 2012, Communicable diseases intelligence quarterly report.

Long-Term Trends in Invasive Haemophilus influenzae Type b Disease among Indigenous Australian Children Following use of PRP-OMP and PRP-T Vaccines

P. McIntyre, R. Menzies, F. Beard, 2015, The Pediatric infectious disease journal.

Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkage.

Bette C Liu, D. Randall, A. Newall, 2021, Vaccine.

Estimated health and economic impact of using high-dose influenza vaccine on respiratory and circulatory plus respiratory hospitalizations of older adults in Australia

E. Thommes, C. Raina MacIntyre, R. Menzies, 2023, Vaccine: X.

Equity in disease prevention : Vaccines for the older adults – Proceedings of a workshop , Melbourne , Australia 20 June 2014

T. Adair, R. MacIntyre, J. Travaglia, 2016 .

Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical.

P. Beutels, J. Wood, A. Newall, 2016, Vaccine.

Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System.

I. Barr, R. Owen, K. Hope, 2007, Communicable diseases intelligence quarterly report.